|

IDOV-Immune (oncolytic vaccinia virus) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • ViroMissile, Inc.1

Indications

  • Liver Disease1
  • Adrenal Gland Tumors1
  • Head and Neck Cancers1
  • Cervical Cancers1
  • Renal Cell Carcinoma1

St Louis, Missouri1 trial

IDOV-Immune for Advanced Solid Tumors

Washington University School of Medicine

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.